SPONSOR
Universiteit Antwerpen
Total Trials
6
Recruiting
6
Phases
Phase 2, Phase 2, Phase 3
Conditions studied: Human Papilloma Virus Infection Type 16StrokeBreast EdemaBreast Cancer Related LymphoedemaBreast Cancer Related LymphedemaTruncal LymphedemaNewly Diagnosed Multiple Myeloma (NDMM)Chemotherapy Induced Peripheral Neuropathy (CIPN)Chronic Shoulder PainRotator Cuff Related Shoulder Pain
Universiteit Antwerpen is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Human Papilloma Virus Infection Type 16, Stroke, Breast Edema, Breast Cancer Related Lymphoedema.
The trial portfolio spans Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universiteit Antwerpen
How many clinical trials has Universiteit Antwerpen sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Universiteit Antwerpen, of which 6 are actively recruiting participants. These trials cover conditions including Human Papilloma Virus Infection Type 16, Stroke, Breast Edema. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universiteit Antwerpen research focus on?
Universiteit Antwerpen clinical trials span Human Papilloma Virus Infection Type 16, Stroke, Breast Edema, Breast Cancer Related Lymphoedema, Breast Cancer Related Lymphedema, and additional conditions. The research pipeline includes Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universiteit Antwerpen clinical trial?
To participate in a Universiteit Antwerpen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universiteit Antwerpen trials with current recruitment status updated daily.
Clinical Trials by Universiteit Antwerpen
NCT07407569 Phase 2
Recruiting
Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination
Human Papilloma Virus Infection Type 16
NCT06296082 Phase 2, Phase 3
Recruiting
Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity
Stroke
NCT07080476
Recruiting
Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.
Breast Edema
NCT07087964
Recruiting
Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients
Newly Diagnosed Multiple Myeloma (NDMM)
NCT06962579
Recruiting
The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy
Chemotherapy Induced Peripheral Neuropathy (CIPN)
NCT07275164
Recruiting
HIIT for Inflammatory-driven Shoulder Pain.
Chronic Shoulder Pain
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology